Contract Notice Detail
Summary Information
Summary Information
Base Total Price:
17,105.200000 Euro
Request Reference:
10C0949623
Request Name:
Aquisição de SECUCINUMAB SC 300MG SOL INJ CAN ao abrigo do CPA 2021/55 para o HFF para o ano de 2023
Phase:
Tendering Phase
State:
Awarded
Description:
Aquisição de SECUCINUMAB SC 300MG SOL INJ CAN ao abrigo do CPA 2021/55 para o HFF para o ano de 2023
Procedure Type:
VortalGOV - Acquisition under a Framework Agreement (via Direct Award)
Lot Name
Lot Base Price
Expected Duration
S1719 - SECUCINUMAB [300 MG/2 ML; SOL INJ; CANETA/ SERINGA]
-
48
(
Days
)
Object of the Contract
Object of the Contract
Type of Contract:
Supplies Acquisition
Main Object CPV Main Category:
Ic19 Amadora 2700 Venteira Amadora Lisboa PORTUGAL
CPV Main Vocabulary
33600000-6 - Pharmaceutical products
CPV Supplementary Vocabulary
Additional Classifications List
Scheduling
Scheduling
Request online publishing date:
11/9/2023 10:56 AM
(UTC 0 hours)
National official publishing date and time (DR):
6/17/2021 10:51 AM
(UTC +1 hour)
Due datetime for receiving replies:
11/13/2023 5:00 PM
(UTC 0 hours)
Financial Settings
Financial Settings
Define Warranties?
No
Contract Documents
Contract Documents
Document Name
Description
Doc Classification
solicitaçãocotação.xlsx
solicitaçãocotação.xlsx
Download
Convite_10C0949623.pdf
Convite_10C0949623.pdf
Download
Object of contract
This contract is subject to renewal?
No
The procurement is related to a project and/or programme financed by European Union funds?
No
Legal, economic, financial and technical information
The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?
No
Questionnaire
Questionnaire
Vision
1
Título do Lote
S1719 - SECUCINUMAB [300 MG/2 ML; SOL INJ; CANETA/ SERINGA]
Preço Base
17 105,20
1.1
Bill of Quantities
Esta lista de preços tem requisitos adicionais. Certifique-se de que tudo está completo em cada linha de artigo.
Código
Descrição
Qt
Unidade
S1719
SECUCINUMAB [300 MG/2 ML; SOL INJ; CANETA/ SERINGA]
20,000000
UN
Comentários
500063524 | Novartis Farma - Produtos Farmacêuticos, S.A. | CPA:2021055/128/0121 | NºAIM:5802640;
Totais
(Os valores mostrados não incluem IVA)
Public Messages
Public Messages
Type
Reference
Subject
Date
No items found...